Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now OTC Markets EXMKT - Delayed Quote • USD Medicine Man Technologies, Inc. (SHWZ) Follow Compare 0.0055 +0.0044 +(378.26%) As of 9:30:21 AM EST. Market Open. All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Schwazze Provides Update on Delayed Filings DENVER, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Medicine Man Technologies, Inc., operating as Schwazze, (OTC: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), is providing an update on its previously announced delayed filings. On November 29, 2024, the Audit Committee of the Company determined, following discussions with Baker Tilly and the Company’s management, that the Company’s previously issued audited consolidated financial statements for the two fiscal years ended December 31, 2023, audited Schwazze Announces Preliminary Third Quarter 2024 Financial Results Optimization Initiatives Lead to Quarter-over-Quarter Improvements in Profitability and Positive Cash Flow from OperationsDENVER, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Medicine Man Technologies, Inc., operating as Schwazze, (OTC: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), today announced preliminary financial and operational results for the third quarter ended September 30, 2024. “We continued to generate momentum from our retail growth and optimization initiatives in Q3, reflected by our Schwazze Announces Second Quarter 2024 Financial Results Growth and Restructuring Initiatives Lead to Quarter-over-Quarter Growth Across all Key Financial Metrics in Q2 Schwazze Management to Host Conference Call Today at 5:00 p.m. Eastern Time DENVER, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Medicine Man Technologies, Inc., operating as Schwazze, (OTC: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), today announced financial and operational results for the second quarter ended June 30, 2024. “We made solid progress on our growth and optimization initia Schwazze Sets Second Quarter 2024 Conference Call for August 13, 2024 at 5:00 p.m. ET DENVER, July 30, 2024 (GLOBE NEWSWIRE) -- Medicine Man Technologies, Inc., operating as Schwazze, (OTC: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), will host a conference call on Tuesday, August 13, 2024 at 5:00 p.m. Eastern time to discuss its financial and operational results for the second quarter ended June 30, 2024. The Company’s results will be reported in a press release prior to the call. The Schwazze management team will host the conference call, followed by a question-and-answ Schwazze Announces Restructuring of February 2025 Debt Obligations DENVER, Colo., July 11, 2024 (GLOBE NEWSWIRE) -- Medicine Man Technologies, Inc., operating as Schwazze, (OTCPK: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), today announced that it has finalized an agreement with two of its lenders to restructure its $15.0 million Altmore, LLC (“Altmore”) Loan Agreement and its $17.0 million Reynold Greenleaf & Associates LLC (“R. Greenleaf”) Promissory Note, both previously due in February 2025. This improves the Company's financial position by extendi Schwazze Announces Transition to OTC Expert Market and Provides Update on Delayed Filing DENVER, July 01, 2024 (GLOBE NEWSWIRE) -- Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), today announced that its common stock will soon transition to the OTC Expert Market, under the ticker symbol “SHWZ” due to the Company’s delayed filing of its Form 10-Q for the period ended March 31, 2024, with the Securities and Exchange Commission (“SEC”). The delay was a result of an SEC Order regarding the Company’s previous auditor, B Schwazze Announces Grand Opening of its 35th New Mexico Dispensary in Bernalillo DENVER, June 07, 2024 (GLOBE NEWSWIRE) -- Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), today announced the grand opening of its 35th New Mexico dispensary, R. Greenleaf Bernalillo. The store is located at 242 US-550, Bernalillo, NM 87004, and operates from 8:00 a.m. to 11:00 p.m. Monday through Saturday and 8:00 a.m. to 9:00 p.m. on Sundays. Senior Vice President of New Mexico Retail, Ken Bair, said, "We are thrilled to expa Schwazze Announces First Quarter 2024 Financial Results Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), today announced financial and operational results for the first quarter ended March 31, 2024. Weekly Roundup on the Cannabis Sector & Psychedelic Sector Key Takeaways; Cannabis Sector Canopy Growth secured $50M financing, and restructured debt with an institutional investor. High Tide appointed a new CFO, as the company eyes long-term growth. SNDL intends to move forward with Parallel and Skymint acquisitions, despites the deals facing litigation. Schwazze settled wage theft claims amidst another legal challenges. Key Takeaways; Psychedelic […] Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), will host a conference call on Wednesday, May 15, 2024 at 5:00 p.m. Eastern time to discuss its financial and operational results for the first quarter ended March 31, 2024. The Company's results will be reported in a press release prior to the call. Medicine Man Technologies, Inc. (PNK:SHWZ) Q4 2023 Earnings Call Transcript Medicine Man Technologies, Inc. (PNK:SHWZ) Q4 2023 Earnings Call Transcript March 27, 2024 Medicine Man Technologies, Inc. misses on earnings expectations. Reported EPS is $-0.43 EPS, expectations were $-0.13. Medicine Man Technologies, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). […] Schwazze Announces Fourth Quarter and Full Year 2023 Financial Results Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe: SHWZ) ("Schwazze" or the "Company"), today announced financial and operational results for the fourth quarter and full year ended December 31, 2023. Schwazze Sets Fourth Quarter and Full Year 2023 Conference Call for March 27, 2024 at 5:00 p.m. ET Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe: SHWZ) ("Schwazze" or the "Company"), will host a conference call on Wednesday, March 27, 2024 at 5:00 p.m. Eastern time to discuss its financial and operational results for the fourth quarter and full year ended December 31, 2023. The Company's results will be reported in a press release prior to the call. Performance Overview Trailing total returns as of 2/24/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return SHWZ S&P 500 YTD -72.50% +1.82% 1-Year -99.59% +17.68% 3-Year -99.68% +39.63%